Patients with pre-existing medical problems have additional potential risks related to any large reconstructive surgery, including chronic pain, blood clots, heart attack, stroke, and even death
Athletic Recovery Designed for the modern athlete
Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial
A REGISTRY-BASED CASE-CONTROL STUDY Guri Hagberg 1,2 , Hkon Ihle-Hansen 3,4 , Tamar Abzhandadze 2,5 , Malin Reinholdsson 2,5 , Adam Viktorisson 2,6 , Henri Pesonen 7 , Hege Ihle-Hansen 4 , Katharina Stibrant Sunnerhagen 2,6 1 Oslo Stroke Unit, Department of Neurology, Oslo University Hospital, Oslo, Norway, 2 Institute of Neuroscience and Physiology, Section for Clinical Neuroscience and Rehabilitation, Gothenburg University, Gothenburg, Sweden, 3 Department of Medicine, Brum Hospital- Vestre Viken Hospital Trust, Drammen, Norway, 4 Research department Brum Hospital, Vestre Viken Hospital Trust, Drammen, Norway, 5 Department of Occupational Therapy and Physiotherapy, Sahlgrenska University Hospital, Gothenborg, Sweden, 6 Neurocare, Sahlgrenska University Hospital, Gothenburg, Sweden, 7 Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway Background and Aims: Patient reported outcome measures (PROMs) could expose meaningful differences but are scarcely investigated in acute stroke trials
The Future of CJC-1295 vs Ipamorelin in Muscle Growth As muscle growth research advances, examining the differences between CJC-1295 vs Ipamorelin may inform the development of growth hormone secretagogues with improved efficacy and safety
